Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2013-05-16

Clinical Trial Update: MEsenchymal StEm Cells for Multiple Sclerosis [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for mesenchymal stem cells as a potential therapy for multiple sclerosis in Phase 1/Phase 2, sponsored by Antonio Uccelli; current status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Antonio Uccelli | Conditions: Multiple Sclerosis | Phase 1, Phase 2 | Status: UNKNOWN